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PURPOSE. To compare the lesion sizes of choroidal neovascularization (CNV) imaged with
spectral-domain (SD) and swept-source (SS) optical coherence tomography angiography
(OCTA) and measured using an automated detection algorithm.
METHODS. Patients diagnosed with CNV were imaged by SD-OCTA and SS-OCTA systems using
3 3 3-mm and 6 3 6-mm scans. The complex optical microangiography (OMAGC) algorithm
was used to generate the OCTA images. Optical coherence tomography A datasets for imaging
CNV were derived by segmenting from the outer retina to 8 lm below Bruch’s membrane. An
artifact removal algorithm was used to generate angiograms free of retinal vessel projection
artifacts. An automated detection algorithm was developed to quantify the size of the CNV.
Automated measurements were compared with manual measurements. Measurements from
SD-OCTA and SS-OCTA instruments were compared as well.
RESULTS. Twenty-seven eyes from 23 subjects diagnosed with CNV were analyzed. No
significant differences were detected between manual and automatic measurements: SD-
OCTA 3 3 3-mm (P ¼ 0.61, paired t-test) and 6 3 6-mm (P ¼ 0.09, paired t-test) scans and
the SS-OCTA 3 3 3-mm (P ¼ 0.41, paired t-test) and 6 3 6-mm (P ¼ 0.16, paired t-test) scans.
Bland-Altman analyses were performed to confirm the agreement between automatic and
manual measurements. Mean lesion sizes were significantly larger for the SS-OCTA images
compared with the SD-OCTA images: 3 3 3-mm scans (P ¼ 0.011, paired sample t-test) and
the 6 3 6-mm scans (P ¼ 0.021, paired t-test).
CONCLUSIONS. The automated algorithm measurements of CNV were in agreement with the
hand-drawn measurements. On average, automated SS-OCTA measurements were larger than
SD-OCTA measurements and consistent with the results from using hand-drawn measure-
ments.
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Choroidal neovascularization (CNV) is a characteristicfeature of late-stage age-related macular degeneration
(AMD) and is characterized by the growth of abnormal blood
vessels from the choroid through Bruch’s membrane and under
the retinal pigment epithelium (type 1) with possible extension
into the subretinal space (type 2).1 Currently the clinical
staging of neovascular AMD is based on fluorescein angiogra-
phy (FA), indocyanine angiography (ICGA), and optical
coherence tomography (OCT) structural imaging. Traditional
OCT imaging can provide three-dimensional structural infor-
mation about the retina and choroid that aids in the diagnosis
and management of exudative neovascular AMD (nvAMD).1,2
However, structural OCT imaging is not able to directly
visualize the functional blood vessels composing the CNV.
Instead, CNV is visualized directly by using the dye-based
angiographic techniques of FA and ICGA.
The recent development of OCT-based angiography (OC-
TA)3–6 allows for the direct visualization of the retinal and
choroidal vasculature. Optical coherence tomography A is fast,
safe, noninvasive, and inexpensive compared with FA and
ICGA. Optical coherence tomography A imaging of CNV has
attracted a great deal of interest.4,7–13 Most studies have used
spectral-domain OCTA (SD-OCTA) systems operating at 840-nm
wavelength, due to the availability of commercial systems.
Copyright 2017 The Authors
iovs.arvojournals.org j ISSN: 1552-5783 1506
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloaded from iovs.arvojournals.org on 05/10/2019
However, light at this wavelength is heavily scattered and
absorbed by the retinal pigment epithelium (RPE) complex,
which can affect the ability to visualize CNV in nvAMD.
Swept-source OCTA (SS-OCTA) utilizes a wavelength around
1000 to 1100 nm, which reduces scattering and absorption of
the RPE complex, allowing for deeper penetration of light into
the choroid.14–18 This longer wavelength is also safer for the eye,
so greater laser power can be used to obtain images compared
with commercially available SD-OCTA instruments, which
should result in improved detection of weak signal scattered
from the choroid. Furthermore, at a given laser power, SS-OCT
has a reduced sensitivity roll-off along the imaging depth range
compared with SD-OCT.19–22 These advantages, combined with
the faster scanning rates and thus denser scanning patterns that
can be achieved with similar acquisition times, would suggest
that SS-OCTA should perform better than SD-OCTA in the
detection of CNV. Novais et al.23 compared the detection of CNV
using both SD-OCTA and SS-OCTA instruments in eyes with
nvAMD, concluding that SS-OCT performed better than SD-OCT.
However, that study used different segmentation schemes for
each image, limiting the general applicability of the results.
While measurements of neovascular lesions are typically
performed by manually outlining the CNV on angiograms, this
strategy is often difficult and labor intensive. To avoid the biases
of manual graders, the need for different segmentation strategies,
and the time-consuming nature of manual grading, we propose
the adoption of a standardized en face segmentation strategy to
visualize OCTA images of CNV and the use of an automated
segmentation algorithm to measure the size of the CNV from
these OCT angiograms. The aim of the current study was to
validate our automated algorithm against manual measurements
performed by expert graders using both SD-OCTA and SS-OCTA
images and to compare the automated measurements of CNV
obtained using the two different instruments.
METHODS
Patient Inclusion and Exclusion Criteria
One hundred fifteen eyes from 90 patients with exudative
AMD were imaged and enrolled at the Bascom Palmer Eye
Institute in a prospective OCT imaging study from October
2015 to April 2016. The Institutional Review Board of the
University of Miami Miller School of Medicine approved the
study, and an informed consent was obtained from all the
patients. The study was performed in accordance with the
tenets of the Declaration of Helsinki and compliant with the
Health Insurance Portability and Accountability Act of 1996.
Thirty-five eyes were excluded because the CNV was not fully
contained within the 333-mm scan area. An additional 53 eyes
were excluded because of signal quality problems with at least
one of the four scans, which included scans with signal
strength below 6 or excessive motion artifacts.
Twenty-seven eyes from 23 patients with neovascular AMD
were identified as candidates for this study. Thirteen (56%) of
the 23 patients were men. Mean patient age was 77.4 years and
ranged from 51 to 88 years. At the time of imaging, 25 of 27
eyes had received prior intravitreal therapy with vascular
endothelial growth factor (VEGF) inhibitors; one eye received
an injection on the day of imaging due to new-onset exudation,
and one eye had CNV without exudation and was being
observed as previously described.20
Imaging Devices and Scanning Protocol
Spectral-domain OCTA and SS-OCTA devices were used in this
study. Each patient recruited in the comparison study was
imaged by both systems at the same visit. Both 333- and 636-
mm scans were acquired from each eye by each system. All
scans were centered on the fovea, and FastTrac motion
correction software (Carl Zeiss Meditec, Inc., Dublin, CA,
USA) was used while the images were acquired.
Spectral-domain OCTA was performed using a commercially
available AngioPlex instrument (Cirrus 5000 HD-OCT system
provided by Carl Zeiss Meditec, Inc.), operating at a central
wavelength of 840 nm and an A-scan rate of 68,000 Hz. The
system provided an axial resolution of ~5 lm in tissue and an
estimated lateral resolution of ~15 lm at the retinal surface.
For the 33 3-mm scans, 245 A-lines formed one B-scan, while
B-scans were acquired at 245 different spatial locations and
repeated four times at each location. This scanning protocol
resulted in a uniform spacing of 12.2 lm between pixels in the
final en face OCTA images. For the 63 6-mm scans, 350 A-lines
for each B-scan and 350 spatial locations were sampled,
resulting in a uniform spacing of 17.1 lm between pixels in the
final en face OCTA images. In contrast to the 33 3-mm scan,
the 63 6-mm scan uses two B-scan repetitions at each spatial
location.
The SS-OCTA instrument (a prototype system provided by
Carl Zeiss Meditec, Inc.) used a swept laser source with a
central wavelength of 1050 nm (1000–1100 nm full band-
width) and operated at 100,000 A-scans per second. The axial
and lateral resolutions of the system were ~5 lm in tissue and
~14 lm at the retinal surface. Due to the faster scanning
speed, a denser sampling strategy was adopted. For 33 3-mm
scans, a 300 3 300-pixel array was used (10.0-lm spacing
between pixels), while for 63 6-mm scans, a 4203 420-pixel
array was used (14.3 lm). The repetition strategy was the same
as described for SD-OCTA scans: four repetitions for 33 3-mm
scans and two repetitions for 63 6-mm scans.
Both the SD-OCT and SS-OCT datasets were processed using
the complex optical microangiography (OMAGC) algo-
rithm24–26 to generate the angiographic signals. A semiauto-
mated segmentation algorithm was applied to identify relevant
retinal layers,27 and manual corrections were carried out as
necessary to ensure an accurate segmentation. In particular,
we evaluated en face angiograms (Fig. 1) produced using a slab
extending from the outer boundary of the outer plexiform
layer to 8 lm beneath Bruch’s membrane (BM). This slab is
referred to as the outer retina to choriocapillaris (ORCC) slab,
and it has been shown to be useful for visualizing important
features of type I and type II CNV.20
Due to the hyperreflection from the RPE, the resulting
ORCC en face image includes projection artifacts from the
overlying retinal blood vessel.28 For better visualization and
detection of the CNV, we developed an artifact removal
algorithm29 to minimize the effect of the projection artifacts
and improve the visualization of CNV (Fig. 1D). These images
were used in the measurements of the lesion sizes as discussed
below.
Automatic Detection of CNV Lesion Size
An automated algorithm was developed to segment CNV in the
en face ORCC images. Figure 2 illustrates the main steps
composing the algorithm. First, the contrast of the artifact-free
ORCC angiogram (Fig. 2A) was enhanced through an adaptive
thresholding method using the following equation:
Ioutðx; yÞ ¼ aIinðx; yÞ þ b ð1Þ
where Iin(x,y) and Iout(x,y) are the input and output images,
respectively, with (x,y) indicating the pixel coordinates in the
image. The parameters a > 0 and b are the gain and bias
parameters, controlling contrast and brightness, respectively.
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In this study, a¼0.5 and b¼ 100 for both the systems based on
the OCT system signal-to-noise ratio and signal strength, which
results in a contrast-enhanced image (Fig. 2B). Next, the
resulting image (Fig. 2B) was low-pass filtered to remove noise
through a convolution operation:
I 0outðx; yÞ ¼ G0*Ioutðx; yÞ ð2Þ
where G0 is a two-dimensional Gaussian low-pass filter
G0ðx; yÞ ¼ 1
r
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and r ¼ 5 was used in this study. Otsu’s adaptive threshold
method30 was subsequently applied to produce a binary image
(Fig. 2C) from which the neovascular border/contour outline
(Fig. 2D) was extracted by morphologic dilation followed by
the Canny edge detection.31 The neovascular lesion size was
calculated by summing the areas of the pixels within the region
bounded by the contour line (Fig. 2E).
Choroidal neovascularization lesion size was measured
using this algorithm on en face ORCC angiograms from both
SD-OCTA and SS-OCTA instruments. In addition, two graders
(JROD and ZY), masked to instrument type that was used to
acquire the image, manually outlined the CNV lesions from the
same artifact-free ORCC angiograms and calculated the
corresponding lesion sizes. Neither of the graders reviewed
the images prior to grading. The two sets of measurements
were analyzed and compared in order to validate our
automated algorithm.
Statistical Analysis
Paired sample t-tests and Bland-Altman analyses32,33 were
performed to detect differences in neovascular lesion size
between manual and automatic measurements and between
the instruments. Pearson product–moment models were used
to investigate the correlation between automatic and manual
measurements for all the groups (including 3 3 3- and 6 3 6-
mm scans on SS-OCTA imaging; 33 3- and 63 6-mm scans on
SD-OCTA imaging) as well as the correlation between SD-OCTA
and SS-OCTA for both 3 3 3- and 6 3 6-mm scans based on
automated area measurements. P values below 0.05 were
considered statistically significant.
RESULTS
Images from 27 eyes of 23 patients were available for this study,
as described in our companion paper.34 For each of these eyes,
both the 3 3 3- and 6 3 6-mm scans from the SD-OCTA and
from the SS-OCTA device were analyzed.
Comparison Between Automatic and Manual
Measurements
Table 1 summarizes the comparisons between the manual and
automated measurements obtained from the two instruments.
No significant differences were found between automatic and
manual measurements for both instruments using the 3 3 3-
mm scans (P ¼ 0.41 and 0. 61 for SS-OCTA and SD-OCTA,
respectively; paired sample t-test) and the 63 6-mm scans (P¼
0.16 and 0.09 for SS-OCTA and SD-OCTA, respectively; paired
sample t-test). These results show that the automated
algorithm produces lesion size measurements comparable to
the manual ones.
Linear regression analyses show statistically significant
relationships between automatic and manual measurements
for all the groups (Fig. 3), with correlation coefficients of 0.898
on the 33 3-mm scans, 0.719 on the 63 6-mm scans using SS-
OCTA imaging, 0.822 on the 33 3-mm scans, and 0.693 on the
63 6-mm scans using SD-OCTA imaging.
Bland-Altman analyses are shown in Figure 4, indicating
strong agreement between automatic and manual measure-
ments. However, we find greater variations of the measure-
ments obtained from the 63 6-mm scans compared with the 3
3 3-mm scans.
FIGURE 1. Outer retina to choriocapillaris (ORCC) optical coherence
tomography angiography (OCTA) images with tailing artifact removal.
(A) Representative cross-sectional OCT structural image with segmen-
tation lines to define the ORCC slab; (B) corresponding OCTA flow
image; (C) na¨ıve en face ORCC angiogram; (D) en face ORCC
angiogram following removal of retinal vessel projection artifacts.
The yellow lines define the segmentation lines for the ORCC layer,
which extends from the outer boundary of outer plexiform layer to 8
lm below Bruch’s membrane.
FIGURE 2. Flow chart of the automated algorithm to segment the
choroidal neovascularization (CNV). (A) The artifact-free ORCC
angiogram. (B) Image contrast of the ORCC angiogram is enhanced
through an adaptive thresholding method. (C) Binary image is obtained
through smoothing and Otsu’s adaptive thresholding methods. (D) The
contour of CNV boundary is detected through morphologic analysis.
(E) The CNV lesion size is measured as the area bounded by the
contour line. CNV, choroidal neovascularization.
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Comparisons Between Two Devices
Figure 5 shows examples of the automated segmentation of
lesion from 33 3- and 63 6-mm scans. For both the devices,
the 33 3-mm angiograms delivered clearer visualization of the
CNV with better contrast and image quality. Swept-source
OCTA angiograms provided a better overall signal-to-noise ratio
and greater vascular details compared with SD-OCTA.
Table 2 summarizes the automated measurements of
neovascular lesions on the two devices. Significant differences
between the instruments were found for both 33 3-mm scan
(P¼0.011, paired sample t-test) and 636-mm scan (P¼0.021,
paired sample t-test) images. The sizes of the CNV were
consistently larger when measured on the SS-OCTA angiograms
compared with the SD-OCTA angiograms.
There was a statistically significant correlation between
automated area measurements on SD-OCTA and SS-OCTA for
both scans, with P < 0.001 and R2 ¼ 0.810 for the 33 3 mm
(Fig. 6A) and P¼ 0.013 and R2¼ 0.223 for 63 6 mm (Fig. 6B),
although the results were more variable for the 6 3 6-mm
scans. Bland-Altman analyses are shown in Figures 6C and 6D.
For 3 3 3-mm scans, the mean difference (bias) is 0.15 mm2,
indicating that SS-OCTA gives consistently larger measurements
for the CNV. The same is true for 63 6 mm, but with a larger
mean difference (0.28 mm2) and standard deviation (SD)
compared with the 33 3-mm scans.
DISCUSSION
Optical coherence tomography angiography is a new imaging
technology that shows great promise for visualizing vascular
pathology in retinal and choroidal diseases.7–14,19–22 Spectral-
domain OCTA and SS-OCTA are two different configurations
capable of performing OCT angiography. However, few studies
have investigated the difference between SD-OCTA and SS-
OCTA for visualizing CNV in AMD. The study conducted by
Novais et al.23 was the first to describe the differences between
these two configurations for imaging CNV in AMD, and the
authors demonstrated that SS-OCTA was better at visualizing
neovascularization beneath the RPE. However, the comparison
was confounded by the use of different slabs for different
scans, as well as the presence of projection artifacts from the
overlying retinal blood vessels. In this study, we adopted a
TABLE 1. Comparison Between Automatic and Manual Measurements of Choroidal Neovascularization
Instrument SS-OCTA SD-OCTA
3 3 3 mm, n ¼ 27 6 3 6 mm, n ¼ 27 3 3 3 mm, n ¼ 27 6 3 6 mm, n ¼ 27
Measurement Automatic Manual Automatic Manual Automatic Manual Automatic Manual
Mean, mm2 1.13 1.17 1.12 1.24 0.99 1.01 0.85 0.74
SD 0.64 0.73 0.59 0.76 0.58 0.56 0.54 0.61
P value 0.41 0.16 0.61 0.09
FIGURE 3. Automated versus manual measurements of CNV for different scan areas and different instruments. (A) SS-OCTA measurements for 333-
mm scans; (B) SS-OCTA measurements for 63 6-mm scans; (C) SD-OCTA measurements for 33 3-mm scans; (D) SD-OCTA measurements for 63 6-
mm scans. SS-OCTA, swept-source optical coherence tomography angiography; SD-OCTA, spectral-domain optical coherence tomography
angiography.
Automated CNV Quantitation Using OCTA IOVS j March 2017 j Vol. 58 j No. 3 j 1509
Downloaded from iovs.arvojournals.org on 05/10/2019
standard ORCC slab to visualize the CNV combined with a
projection artifact removal algorithm.29 Moreover, we intro-
duced an automated segmentation algorithm to quantify the
CNV and validated this algorithm against hand-drawn measure-
ments performed by expert graders. Automated quantification
could eliminate possible subjective bias in manual measure-
ment of CNV, and, more importantly, can produce fast, easily
obtained measurements that could be useful in a clinical
setting for the longitudinal monitoring of lesion growth, a
strategy that should prove important in the management of
CNV in nvAMD patients.
In the current study, we validated our algorithm by
analyzing the agreement between automated and manual
measurements of CNV. We found no significant difference
between the two methods in all cases, although the variability
was larger in the 63 6-mm scans than in the 33 3-mm scans.
Our results indicated that our automated algorithm performs
well on both SD-OCTA and SS-OCTA systems, and it is useful for
quantitative, longitudinal assessment of CNV.
We also compared the differences in automated measure-
ments of lesion sizes across our instruments with different scan
sizes. Significant differences were found between the two
FIGURE 4. Bland-Altman analyses for automatic and manual measurements. (A) 33 3-mm scans by SS-OCTA. (B) 63 6-mm by SS-OCTA. (C) 33 3
mm by SD-OCTA. (D) 63 6 mm by SD-OCTA. The thick line represents the mean difference, and top and bottom dotted lines indicate the 95%
limits of agreement (mean difference 6 1.96 standard deviation [SD] of the difference). The line of equality is shown as the thin dotted line across
the zero-difference line. The shaded areas represent the confidence interval limits for mean and agreement limits. SS-OCTA, swept-source optical
coherence tomography angiography; SD-OCTA, spectral-domain optical coherence tomography angiography.
FIGURE 5. Automated measurements of choroidal neovascularization (CNV) based on artifact-free ORCC angiograms using both 333- and 636-mm
scans obtained using SS-OCTA (top row) and SD-OCTA (bottom row) imaging. (A, C, E, G) ORCC angiograms. (B, D, F, H) ORCC angiograms
showing the CNV segmentation. SS-OCTA, swept-source optical coherence tomography angiography; SD-OCTA, spectral-domain optical coherence
tomography angiography; ORCC, outer retina to choriocapillaris.
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instruments on both scan patterns (P¼0.011 for 333 mm and
P ¼ 0.021 for 6 3 6 mm, paired sample t-test). There was a
statistically significant correlation between SD-OCTA and SS-
OCTA measurements for both types of scans. However, the SS-
OCTA scans produced consistently larger lesion sizes. This
result appears to indicate that SS-OCTA might be able to
visualize and measure more of the CNV compared with SD-
OCTA imaging. This is consistent with the expected theoretical
advantages of the SS-OCT system. In particular, the use of a
1050-nm wavelength in the SS-OCTA instrument reduces the
optical scattering and absorption from the RPE complex and
allows for the safe use of greater laser power, resulting in
increased signal from structures below the RPE, including type
1 CNV. Moreover, SS-OCT systems have the advantage of a
smaller sensitivity roll-off compared with SD-OCT.35 These
considerations should lead to better results when imaging CNV
using SS-OCTA and would explain larger lesion area measure-
ments, as we found both using manual segmentations and our
automated algorithm.
The differences between the SS-OCTA and SD-OCTA manual
and automated measurements of CNV for the 63 6- and 33 3-
mm scans were statistically significant. This may be explained
by the contrast-to-noise ratio (CNR) of the ORCC angiograms.
From the point of view of image processing and pattern
recognition, the CNR of the images would affect both the
manual and automated measurements. For the images with
higher CNR, for example, 33 3-mm scans, both the automated
and manual measurements would provide reliable measure-
ments of CNV; therefore, it is not a surprise that they deliver
similar values (Table 1). For 6 3 6-mm scans, the ORCC
angiograms have lower CNR values, which may challenge the
automated algorithm’s ability to quantitate the true size of the
CNV. The larger measurement using the manual approach in
lower CNR images may be due to grader’s bias because
experienced graders may guess at the places where the CNR is
low.
There are a number of limitations in our study. The sample
size is relatively small. Also, OCT signal strength was not
explicitly considered in the development of the automated
algorithm or in the assessment of the results. Therefore, it is
not clear how the OCT signal strength might affect CNV
measurements.
In conclusion, we have developed an automated algorithm
to quantify the size of CNV in nvAMD. The automated results
have been validated against manual measurements, and we
carried out a comparison between SD-OCTA and SS-OCTA
instruments. Our results show that SS-OCTA imaging delivers
consistently better image quality, higher contrast on the ORCC
angiograms, and larger measurements of CNV compared with
FIGURE 6. Linear regression and Bland-Altman analyses comparing SS-OCTA and SD-OCTA images on the 3 3 3- and 6 3 6-mm angiograms. (A)
Comparison of lesion areas obtained with the different instruments for the 3 3 3-mm scans. (B) Comparison of lesion areas obtained with the
different instruments for the 636-mm scans. (C) Bland-Altman analysis for the lesion areas obtained with the different instruments for the 333-mm
scans. (D) Bland-Altman analysis for the lesion areas obtained with the different instruments for the 63 6-mm scans. For the Bland-Altman analyses,
thick lines indicate the mean difference, and top and bottom dotted lines indicate the 95% limits of agreement (mean difference 6 1.96 standard
deviation [SD] of the difference). The line of equality is shown as the thin dotted line across the zero-difference line. The shaded areas represent
the confidence interval limits for mean and agreement limits. CNV, choroidal neovascularization; SS-OCTA, swept-source optical coherence
tomography angiography; SD-OCTA, spectral-domain optical coherence tomography angiography.
TABLE 2. Comparison of Neovascular Lesion Sizes Measured Automat-
ically From the SS-OCTA and SD-OCTA Images
Measure
3 3 3 mm, n ¼ 27 6 3 6 mm, n ¼ 27
SS-OCTA SD-OCTA SS-OCTA SD-OCTA
Mean, mm2 1.13 0.99 1.12 0.85
SD 0.64 0.58 0.59 0.54
P value 0.011 0.021
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SD-OCTA imaging. Robust and reliable automated measure-
ments may help clinicians in their ability to assess the
longitudinal changes in the size of CNV during therapy and
help improve the retreatment paradigms.
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